🇺🇸 FDA
Drug

tasimelteon

Brand: HETLIOZ

approved

Quick answer

tasimelteon (HETLIOZ), is a pharmaceutical active ingredient, associated with Vanda Pharmaceuticals, with approved status in the US.

Key facts

INN
tasimelteon
Brand
HETLIOZ
Route
ORAL
Formulation
CAPSULE
Originator
Vanda Pharmaceuticals

Related patents

patent

US 12049457

Highly purified pharmaceutical grade tasimelteon

Expires Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11759446

Liquid tasimelteon formulations and methods of use thereof

Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11760740

Highly purified pharmaceutical grade tasimelteon

Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11566011

Highly purified pharmaceutical grade tasimelteon

Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11203581

Highly purified pharmaceutical grade tasimelteon

Expires Mon Dec 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11202770

Liquid tasimelteon formulations and methods of use thereof

Expires Mon Dec 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10829465

Highly purified pharmaceutical grade tasimelteon

Expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10611744

Highly purified pharmaceutical grade tasimelteon

Expires Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is tasimelteon?

tasimelteon (HETLIOZ), is a pharmaceutical active ingredient, associated with Vanda Pharmaceuticals, with approved status in the US.

What is the brand name for tasimelteon?

HETLIOZ is a marketed brand name for tasimelteon. Check FDA Drugs@FDA for the current US label holder.